On January 9, 2020 Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, reported that it will present at the 38th Annual J.P. Morgan Healthcare Conference (Press release, Novavax, JAN 9, 2020, View Source [SID1234552984]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Date and Time: Thursday, January 16, 11:00 – 11:25 a.m. P.T.
Location: California West, Westin St. Francis Hotel, San Francisco
Live webcast: www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section www.novavax.com.